文献速递物质与行为成瘾

列联管理治疗兴奋剂使用障碍与死亡风险的关联:队列研究

Contingency Management for Stimulant Use Disorder and Association With Mortality: A Cohort Study.
PubMed 文献 · Am J Psychiatry · 2025-09-10

结果显示,接受列联管理者一年内死亡风险降低41%(校正风险比=0.59,95%CI=0.36,0.95)。这是首个在真实医疗环境中提示列联管理与兴奋剂使用障碍患者死亡风险降低相关的证据。

要点

  • 列联管理是兴奋剂使用障碍最有效的治疗,但长期对死亡率的影响此前不明。
  • 真实医疗环境中,接受列联管理的患者一年死亡风险降低41%(校正风险比=0.59,95%CI=0.36,0.95)。
  • 该研究为列联管理改善兴奋剂使用障碍患者长期生存提供了首个真实世界证据。

核心结论

  • 在真实医疗环境中,列联管理与兴奋剂使用障碍患者一年内死亡风险降低相关(校正风险比=0.59,95%CI=0.36,0.95)。

研究设计与样本

  • 纳入1481例接受列联管理的兴奋剂使用障碍患者与1481例匹配对照,主要结局为索引列联管理访视后一年内死亡率。
  • 全因死亡率数据来自国家死亡索引并与电子健康记录链接,采用分层Cox比例风险模型估计校正风险比。

主要发现

  • 接受列联管理的患者一年内死亡可能性比未接受者低41%(校正风险比=0.59,95%CI=0.36,0.95)。

临床怎么用

  • 在真实医疗环境中考虑使用列联管理治疗兴奋剂使用障碍,可能有助于降低患者一年内死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: While opioid overdose has begun to decrease in recent years, stimulant overdose has continued to increase and has not been adequately addressed. Unlike opioid use disorder, there are no medications approved by the U.S. Food and Drug Administration to treat stimulant use disorder (StUD). The most effective treatment is contingency management (CM), a behavioral intervention that provides tangible rewards to reinforce target behaviors, such as biochemically verified abstinence. Despite the effectiveness of CM on near-term substance use behaviors, the long-term impact on key outcomes such as mortality are unclear. The objective of this work was to examine whether patients with StUD who receive CM have a decreased risk of mortality. METHODS: This was a retrospective cohort study of patients with StUD who received or did not receive CM, using linked electronic health records and death records in the largest integrated health system in the United States, the Veterans Health Administration (VHA), from July 2018 through December 2020. The primary outcome was mortality in the year following the index CM visit. All-cause mortality data were obtained from the National Death Index and linked to electronic health record data. Adjusted hazard ratios were estimated using stratified Cox proportional hazards models. RESULTS: A total of 1,481 patients with StUD who received CM were included alongside 1,481 matched control subjects. Over the 1-year follow-up period, those who received CM were 41% less likely to die (adjusted hazard ratio=0.59, 95% CI=0.36, 0.95) than those who did not receive CM. CONCLUSIONS: This study provides the first evidence that CM use in real-world health care settings is associated with reduced risk of mortality among patients with StUD.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Coughlin LN, Tomlinson DC, Zhang L, et al. Contingency Management for Stimulant Use Disorder and Association With Mortality: A Cohort Study. Am J Psychiatry. 2025. PMID: 40926572. doi:10.1176/appi.ajp.20250053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。